Acquiring Company
IQVIA
Acquired Company
Charles River Laboratories
DurhamWilmingtonInformation TechnologyBiotechnologyHealth CareAnalyticsLife ScienceBiotechnologyHealth CareScience And EngineeringPharmaceuticalDescription
Iqvia Holdings Inc. has acquired specific drug discovery assets from Charles River Laboratories for approximately $145 million. This acquisition enhances Iqvia's European operations and integrates proven revenue-generating units into its global network. Charles River Labs is divesting these assets to improve margins as part of a corporate restructuring strategy.
Quick answer
IQVIA is acquiring Charles River Laboratories for $145 million, announced February 26, 2026. IQVIA is based in Durham, North Carolina, United States.
- How much did IQVIA pay for Charles River Laboratories?
- The reported deal value is $145 million.
- What does IQVIA do?
- IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries.
- Where are IQVIA and Charles River Laboratories based?
- IQVIA is based in Durham, North Carolina, United States. Charles River Laboratories is based in Wilmington, Massachusetts, United States.
- Who are the decision-makers at IQVIA?
- Fundz holds 1 contact at IQVIA. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Analytics and Life Science
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Garda Therapeutics to acquire Assertio for $125.1M, $125M (April 8, 2026)
- Lupin completes acquisition of VISUfarma (April 2, 2026)
- Merck acquires JSR Life Sciences' chromatography business (April 2, 2026)
- Eli Lilly to acquire Centessa Pharmaceuticals (March 31, 2026)
- Servier Pharmaceuticals to acquire Day One Biopharma (March 11, 2026)
- Indegene Limited acquires two UK consulting firms (March 1, 2026)
Who to call at IQVIA, and when
When IQVIA changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day IQVIA raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at IQVIA, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at IQVIA. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment IQVIA makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Charles River Laboratories?
Charles River Laboratories was acquired by IQVIA, based in Durham. The deal was reported on February 26, 2026. IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA is publicly traded (IQV) and operates in Information Technology.
When did IQVIA acquire Charles River Laboratories?
IQVIA's acquisition of Charles River Laboratories was reported on February 26, 2026. Iqvia Holdings Inc. has acquired specific drug discovery assets from Charles River Laboratories for approximately $145 million. This acquisition enhances Iqvia's European operations and integrates proven revenue-generating units into its global network. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Charles River Laboratories do?
Charles River Laboratories is a leading provider of drug development services. The company specializes in preclinical and clinical laboratory services for the pharmaceutical and biotechnology industries. It is publicly traded (CRL), operating in Biotechnology, and is based in Wilmington.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.